Tenaya Therapeutics (TNYA) Assets (2020 - 2026)

Tenaya Therapeutics has reported Assets for 7 years, with the latest figure at $135.1 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 6.17% year-over-year to $135.1 million; the trailing twelve-month figure through Mar 2026 stood at $135.1 million (down 6.17% YoY), and the FY2025 full-year result was $146.9 million, up 22.5% from the prior year.
• Assets for Q1 2026 stood at $135.1 million, down from $146.9 million in the prior quarter.
• The five-year high for Assets was $281.5 million in Q1 2022, with the low at $105.0 million in Q3 2025.
• Average Assets over 5 years is $184.4 million, with a median of $170.5 million recorded in 2023.
• Year-over-year, Assets jumped 63.12% in 2022 and plunged 38.87% in 2023.
• Tracing TNYA's Assets over 5 years: stood at $278.9 million in 2022, then plunged by 38.87% to $170.5 million in 2023, then slipped by 29.66% to $119.9 million in 2024, then gained by 22.5% to $146.9 million in 2025, then decreased by 8.07% to $135.1 million in 2026.
• The last three Assets figures came in at $135.1 million (Q1 2026), $146.9 million (Q4 2025), and $105.0 million (Q3 2025), per Business Quant data.

Peer Comparison